+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cell Therapy Global Market Report 2022: By Type, By Cell, By Application, By End-User

  • PDF Icon

    Report

  • 175 Pages
  • March 2022
  • Region: Global
  • The Business Research Company
  • ID: 5553696
Stem Cell Therapy Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global stem cell therapy market.



This report focuses on stem cell therapy market which is experiencing strong growth. The report gives a guide to the stem cell therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for the stem cell therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Stem Cell Therapy market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider stem cell therapy market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
  • The stem cell therapy market section of the report gives context. It compares the stem cell therapy market with other segments of the stem cell therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, stem cell therapy indicators comparison

Scope


Markets Covered:


1) By Type: Allogeneic Stem Cell Therapy; Autologous Stem Cell Therapy
2) By Cell Source: Adult Stem Cells; Induced Pluripotent Stem Cells; Embryonic Stem Cells
3) By Application: Musculoskeletal Disorders; Wounds and Injuries; Cancer; Autoimmune Disorders; Others
4) By End-User: Hospitals; Clinics

Companies Mentioned: Anterogen; JCR Pharmaceuticals; Medipost; Osiris Therapeutics; Pharmicell; Astellas Pharma; Cellectis; Celyad

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Frequently Asked Questions about the Global Stem Cell Therapy Market

What is the estimated value of the Global Stem Cell Therapy Market?

The Global Stem Cell Therapy Market was estimated to be valued at $11.99 billion in 2022.

What is the growth rate of the Global Stem Cell Therapy Market?

The growth rate of the Global Stem Cell Therapy Market is 15.3%, with an estimated value of $21.17 billion by 2026.

What is the forecasted size of the Global Stem Cell Therapy Market?

The Global Stem Cell Therapy Market is estimated to be worth $21.17 billion by 2026.

Who are the key companies in the Global Stem Cell Therapy Market?

Key companies in the Global Stem Cell Therapy Market include Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad and Gamida Cell.

Table of Contents

1. Executive Summary2. Stem Cell Therapy Market Characteristics3. Stem Cell Therapy Market Trends And Strategies4. Impact Of COVID-19 On Stem Cell Therapy
5. Stem Cell Therapy Market Size And Growth
5.1. Global Stem Cell Therapy Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Stem Cell Therapy Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Stem Cell Therapy Market Segmentation
6.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy
6.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
6.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cancer
  • Autoimmune Disorders
  • Others
6.4. Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals

7. Stem Cell Therapy Market Regional And Country Analysis
7.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Stem Cell Therapy Market
8.1. Asia-Pacific Stem Cell Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Stem Cell Therapy Market
9.1. China Stem Cell Therapy Market Overview
9.2. China Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Stem Cell Therapy Market
10.1. India Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Stem Cell Therapy Market
11.1. Japan Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Stem Cell Therapy Market
12.1. Australia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Stem Cell Therapy Market
13.1. Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Stem Cell Therapy Market
14.1. South Korea Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Stem Cell Therapy Market
15.1. Western Europe Stem Cell Therapy Market Overview
15.2. Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Stem Cell Therapy Market
16.1. UK Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Stem Cell Therapy Market
17.1. Germany Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Stem Cell Therapy Market
18.4. France Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Stem Cell Therapy Market
19.1. Eastern Europe Stem Cell Therapy Market Overview
19.2. Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Stem Cell Therapy Market
20.1. Russia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Stem Cell Therapy Market
21.1. North America Stem Cell Therapy Market Overview
21.2. North America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Stem Cell Therapy Market
22.1. USA Stem Cell Therapy Market Overview
22.2. USA Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Stem Cell Therapy Market
23.1. South America Stem Cell Therapy Market Overview
23.2. South America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Stem Cell Therapy Market
24.1. Brazil Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Stem Cell Therapy Market
25.1. Middle East Stem Cell Therapy Market Overview
25.2. Middle East Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Stem Cell Therapy Market
26.1. Africa Stem Cell Therapy Market Overview
26.2. Africa Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Stem Cell Therapy Market Competitive Landscape And Company Profiles
27.1. Stem Cell Therapy Market Competitive Landscape
27.2. Stem Cell Therapy Market Company Profiles
27.2.1. Anterogen
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. JCR Pharmaceuticals
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Medipost
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Osiris Therapeutics
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Pharmicell
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Stem Cell Therapy Pipeline Analysis29. Key Mergers And Acquisitions In The Stem Cell Therapy Market30. Stem Cell Therapy Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer

Executive Summary

Major players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, ReNeuron Group, Takeda Pharmaceuticals, Magellan, Kolon TissueGene, Stemedica Cell Technologies, Holostem Terapie Avanzate S.r.l., NuVasive, RTI Surgical and AlloSource.

The global stem cell therapy market is expected to grow from $10.67 billion in 2021 to $11.99 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $21.17 billion in 2026 at a CAGR of 15.3%.

The stem cell therapy market consists of the sales of stem cell therapy and related services by entities (organizations, sole traders, and partnerships) that provide stem cell therapy. Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased patient, dysfunctional or injured tissue using stem cells or their derivatives. Only goods and services traded between entities or sold to end consumers are included.

The main types of stem cell therapy are allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell transplantation involves transferring stem cells from a healthy person (the donor) to the patient's body after high-intensity chemotherapy or radiation,. The various sources of cell include adult stem cells; induced pluripotent stem cells and embryonic stem cells that are used for the treatment of musculoskeletal disorders; wounds and injuries; cancer; autoimmune disorders and others. The therapies are used by hospitals and clinics.

North America was the largest region in the stem cell therapy market in 2021. Middle East is expected to be the largest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.

The high cost of stem cell therapy is expected to limit the growth of the stem cell therapy market. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for chronic diseases has impacted the health conditions of the population and has led to a low average life expectancy. According to the DVCSTEM, the average cost of stem cell therapy in the USA is between $20,000 to $25,000, in Mexico, it is $33,000, in Central America, it is $30,000, and in Asia, it is $50,000, thus restraining the growth of the market.

The companies in the stem cell therapy market are increasingly investing in strategic partnerships. The strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other. For instance, in June 2020, Shanghai Cell Therapy Group (SHCell) has recently begun a six-year research collaboration with Professor Qi-Long Ying of the University of Southern California (USC). The Ying laboratory hopes to develop conditions for long-term ex vivo expansion of mouse and human hematopoietic stem and progenitor cells through the project, which is supported by $3.6 million from the Baize Plan Fund.

In September 2019, Vertex Pharmaceuticals Inc, a US-based biopharmaceutical company, announced its decision to acquire Semma Therapeutics, a private biotechnology company, for $950 million. The acquisition is expected to align with Vertex’s strategy of investing in scientific innovation that creates transformative medicine for patients with serious diseases. Semma Therapeutics is a US-based company that is involved in using stem cell therapy for diabetes treatment.

The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Anterogen
  • JCR Pharmaceuticals
  • Medipost
  • Osiris Therapeutics
  • Pharmicell
  • Astellas Pharma
  • Cellectis
  • Celyad
  • Novadip Biosciences
  • Gamida Cell
  • Capricor Therapeutics
  • Cellular Dynamics
  • CESCA Therapeutics
  • DiscGenics
  • OxStem
  • Mesoblast
  • ReNeuron Group
  • Takeda Pharmaceuticals
  • Magellan
  • Kolon TissueGene
  • Stemedica Cell Technologies
  • Holostem Terapie Avanzate S.r.l.
  • NuVasive
  • RTI Surgical
  • AlloSource

Methodology

Loading
LOADING...